1997
DOI: 10.1161/01.str.28.3.537
|View full text |Cite
|
Sign up to set email alerts
|

Variables Associated With Hospital Arrival Time After Stroke

Abstract: Patients with milder symptoms, for whom treatment might be more effective, were less likely to arrive in time for therapy. The proposed model of the relationship between the delay in hospital presentation after a stroke and the clinical efficiency of a given treatment might be useful for planning future clinical trials on early stroke treatment and predicting the impact of an educational program aimed at shortening arrival time.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
19
2
1

Year Published

1999
1999
2012
2012

Publication Types

Select...
3
3
1

Relationship

0
7

Authors

Journals

citations
Cited by 92 publications
(25 citation statements)
references
References 20 publications
3
19
2
1
Order By: Relevance
“…Nevertheless, efficacy of reperfusion therapy decreases with time. In the literature, only about 30% of acute stroke patients are seen at the ED within 2 h of stroke onset (42% in the present study) [3, 13, 32, 34]. Door-to-needle time was 33 min less in the P1 group than in the P0 group, but the difference was not significant.…”
Section: Discussioncontrasting
confidence: 64%
See 2 more Smart Citations
“…Nevertheless, efficacy of reperfusion therapy decreases with time. In the literature, only about 30% of acute stroke patients are seen at the ED within 2 h of stroke onset (42% in the present study) [3, 13, 32, 34]. Door-to-needle time was 33 min less in the P1 group than in the P0 group, but the difference was not significant.…”
Section: Discussioncontrasting
confidence: 64%
“…In other series from various countries and different organizations of the health care systems, the percentage of patients arriving within 3 h ranged between 24 and 59% [8,9,10,11,12,13,14,15,16,27,28,29]. …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This indicates the relevance of immediate treatment in ICH patients and leads the focus to younger patients with low comorbidity. In addition to these findings, we here show that the clinically worse patients might represent the majority of admitted patients in the hyperacute stages of the disease [12, 13]. As the initial GCS score is strongly associated with a poor outcome [1, 2], patients of the NOVO7 and FAST trials might reflect a collective with a priori assigned favorable prognosis because of their relatively high median GCS score (i.e.…”
Section: Discussionmentioning
confidence: 61%
“…While the biological signal could be confirmed, the pivotal phase III trial did not have any impact on outcome [11]. There have only been few studies – with focus on ischemic stroke rather than on ICH – investigating possible associations between time window from symptom onset until hospital admission and severity of clinical presentation [12,13,14]. In this study we analyzed whether demographic, clinical and neuroradiological parameters are associated with time to admission in patients with ICH.…”
Section: Introductionmentioning
confidence: 99%